BMS-986253 drug page Clinical trials

Trials with BMS-986253

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
1Recruiting
1Countries
353Planned patients

Showing 1–1 of 1

Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer
Recruiting Phase 2 353 patients NCT03026140

In this exploratory study, patients with stage 1-3 adenocarcinoma of the colon with no signs of distant metastases will be treated with short-term immunotherapy + novel IO combinations (i.e. anti-IL 8, COX2-inhibitors, anti-LAG3). This tre…

Netherlands Mar 2017 – Mar 2032 Interventional

Where the recruiting trials are